Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines

Neuropathology and Applied Neurobiology

Volumn 22, Issue 1, 1996, Pages 3-11

  Wisniewski, H M ^a   Wegiel, J ^a   Kotula, L ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Microglia; Myocytes; Neurofibrillary tangles; Plaques

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ALZHEIMER DISEASE; CELL ULTRASTRUCTURE; CHROMOSOME 1; CHROMOSOME 14; CHROMOSOME 19; CHROMOSOME 21; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; MICROGLIA; MUSCLE CELL; NERVE CELL; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE; TISSUE CULTURE; TRANSGENIC MOUSE; ANIMAL; DISEASE MODEL; HUMAN; MOUSE; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MICE;

EID: 0030038894     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1996.tb00839.x     Document Type: Review

References (61)

1. Barinaga M. New Alzheimer's gene found. Science 1995; 268: 1845-6
2. Beal MF, Hyman BT, Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? TINS 1993; 16: 125-31
3. Bobinski M, Wegiel J, Wisniewski HM et al. Neurofibrillary pathology - correlation with hippocampal formation atrophy in Alzheimer disease. Submitted to Neurobiol Aging
4. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59
5. Braak H, Braak E. Pathology of Alzheimer's disease. In Neurodegenerative Diseases, Ed. DB Calne. Philadelphia: WB Saunders Company, 1994: 585-613
6. Clark RF, Goate AM. Molecular genetics of Alzheimer's disease. Arch Neurol 1993; 50: 1162-72
7. Cork LC, Masters C, Beyreuther K, Price DL. Development of senile plaques. Relationships of neuronal abnormalities and amyloid deposits. Am J Pathol 1990; 137: 1383-92
8. Colman CW. Report of Alzheimer's disease working group A. Neurobiol Aging 1994; 15: S17-S22
9. Frackowiak J, Zoltowska A, Wisniewski HM. Non-fibrillar β-amyloid protein is associated with smooth muscle cells of vessel walls in Alzheimer disease. J Neuropath Exp Neurol 1994; 53: 637-45
10. Fukuchi K-I, Kunkel DD, Ogburn CE et al. Constitutive overexpression of the C-terminus of the human β-amyloid precursor protein in multiple tissues of transgenic mice. Submitted to PNAS
11. Fukuchi K-I, Ogburn CE, Smith AC et al. Transgenic animal models of Alzheimer's disease. Ann NY Acad Sci 1994; 695: 217-23
12. Games D, Adams D, Alessandrini R et al. Development of neuropathology similar to Alzheimer's disease in transgenic mice overexpressing the V717F β-amyloid precursor protein. Nature 1995; 373: 523-7
13. Glenner GG, Henry JR, Fujihara S. Congophilic angiopathy in the pathogenesis of Alzheimer's degeneration. Ann Pathol 1981; 1: 120-9
14. Gowing E, Roher AE, Woods AS et al. Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzhetmer disease. J Biol Chem 1994; 269: 10987-90
15. Higgins LS, Catalano R, Quon D, Cordell B. Transgenic mice expressing human β-APP751, but not mice expressing β-APP695, display early Alzheimer's disease-like histopathology. Ann NY Acad Sci 1994; 695: 224-7
16. Howland DS, Savage MJ, Huntress FA et al. Mutant and native human β-amyloid precursor proteins in transgenic mouse brain. Neurobiol Aging, in press
17. Hoyer S. Brain oxidative energy and related metabolism, neuronal stress, and Alzheimer's disease: a speculative synthesis. J Geriatric Psychiatry Neurol 1993; 6: 3-13
18. Joachim CL, Morris JH, Selkoe DJ. Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease. Am J Pathol 1989; 135: 309-19
19. Kammesheidt A, Boyce HM, Spanoyannis AF et al. Deposition of β/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci USA 1992; 89: 10857-61
20. Khachaturian ZS. Scientific opportunities for developing treatments for Alzheimer's disease: proceedings of research planning workshop 1. Neurobiol Aging 1994 15: S11-S15
21. Kida E, Wisniewski KE, Wisniewski HM. Early amyloid-β deposits show different immunoreactivity to the amino- and carboxy-terminal regions of β-peptide in both Alzheimer's disease and Down's syndrome brain. Neurosci Lett 1995; 193: 1-4
22. Lamb BT, Sisodia SS, Lawler AM et al. Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature Genetics 1993; 5: 22-30
23. Lassmann H, Bancher C, Breitschopf H et al. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 1995; 89: 35-41
24. Levy-Lahad E, Wijsman EM, Nemens E et al. A familial Alzheimer's disease locus on chromosome 1. Science 1995; 269: 970-3
25. Levy-Lahad E, Wasco W, Poorkaj P et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973-7
26. Mann DMA. The role of microglial cells in plaque formation in Alzheimer's disease. In Alzheimer's Disease: Advances in Clinical and Basic Research, Eds B Corain, K Iqbal, M Nicolino, B Winblad, HM Wisniewski, PO Zatta. Chichester: John Wiley, 1993: 159-64
27. Mann DMA, Jones D, South PW, Snowden JS, Neary D. Deposition of amyloid β protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of β protein in neurodegenerative disease. Acta Neuropathol 1992; 83: 415-9
28. Martin LJ, Pardo CA, Cork LC, Price DL. Synaptic pathology and glial responses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex. Am J Pathol 1994; 145: 1358-81
29. Masters CL, Beyreuther K. Molecular neuropathology of Alzheimer's disease. Arzneimittelforschung 1995; 45: 410-2
30. Masters CL, Martins R, Simms G et al. The molecular basis of amyloid protein deposition in Alzheimer's disease and the unconventional virus diseases. In Familial Alzheimer's Disease, Eds GD Miner, R Richter, JP Blass, JL Valentine, LA Winters-Miner. New York: Marcel Dekker, 1989: 173-82
31. Mazur-Kolecka B, Frackowiak J, Wisniewski HM. Apolipoproteins E3 and E4 induce, and transthyretin prevents accumulation of the Alzheimer's β-amyloid peptide in cultured vascular smooth muscle cells. Brain Res. in press
32. Pappolla MA, Omar RA, Vinters HV. Image analysis microspectroscopy shows that neurons participate in the genesis of subset of early primitive (diffuse) senile plaques. Am J Pathol 1991; 139: 599-607
33. Perry GA, Smith MA. Senile plaques and neurofibrillary tangles: What role do they play in Alzheimer's disease? Clin Neurosci 1993; 1: 199-203
34. Pluta R, Kida E, Lossinsky AS, Golabek AA, Mossakowski M, Wisniewski HM. Complete cerebral ischaemia with short-term survival in rats induced by cardiac arrest. I. Extracellular accumulation of Alzheimer's β-amyloid protein precursor in the brain. Brain Res 1994; 649: 323-8
35. Probst A, Langui D, Ipsen S, Robakis N, Ulrich J. Deposition of β/A4 protein along neuronal plasma membranes in diffuse senile plaques. Acta Neuropathol 1991; 83: 21-9
36. Quon D, Wang Y, Catalano R, Scardini JM, Murakami K, Cordell B. Formation of β-amyloid deposits in brains of transgenic mice. Nature 1991; 352: 239-41
37. Sandhu FA, Salim M, Zain SB. Expression of the human β-amyloid protein of Alzheimer's disease specifically in the brains of transgenic mice. J Biol Chem 1991; 266: 21331-4
38. Sasahara M, Fries JWU, Raines EW et al. PDGF β-chain in neurons of the central nervous system, posterior pituitary, and in transgenic model. Cell 1991; 64: 217-27
39. Selkoe, DJ. Deciphering Alzheimer's disease: molecular genetics and cell biology yield major clues. J NIH Res 1995; 7: 57-64
40. Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 1995; 375: 754-60
41. Smith C, Anderton BH. The molecular pathology of Alzheimer's disease: are we closer to understanding the neurodegenerative process? Neuropathol Appl Neurobiol 1994; 20: 322-38
42. Trojanowski JQ, Schmidt ML, Shin R-W, Bramblett GT, Goedert M, Lee VM-Y. From pathological marker to potential mediator of neuronal dysfunction and degeneration in Alzheimer's disease. Clin Neurosci 1993; 1: 184-91
43. Trojanowski JQ, Shin R-W, Schmidt ML, Lee VM-Y. Relationship between plaques, tangles and dystrophic processes in Alzheimer's disease. Neurobiol Aging 1995; 16: 335-40
44. Wegiel J, Wisniewski HM. The complex of microglia cells and amyloid star in three-dimensional reconstruction. Acta Neuropathol 1990; 81: 116-24
45. Wegiel J, Wisniewski HM, Dziewiatkowski J, Popovitch ER, Tarnawski M. Differential susceptibility to neurofibrillary pathology among patients with Down syndrome. Submitted to Dementia: in Press
46. Wegiel J, Wisniewski HM, Dziewiatkowski J et al. Fibrillar and non-fibrillar amyloid in the brain of aged dogs. In Research Advances in Alzheimer's Disease and Related Disorders. Eds K Iqbal, J Mortimer, B Winblad, HM Wisniewski. Chichester: John Wiley, 1995: 703-7
47. Westermark P. Amyloid and polypeptide hormones: what is their interrelationship? Amyloid: Int J Exp Clin Invest 1994; 1: 47-60
48. Wisniewski HM, Currie JR, Barcikowska M, Robakis NK, Miller DL. Alzheimer's disease, a cerebral form of amyloidosis. In Immunology and Alzheimer's Disease. Eds A Pouplard- Barthelaix, J Emile, Y Christen, Berlin: Springer-Verlag, 1988: 1-6
49. Wisniewski, HM, Frackowiak J, Mazur-Kolecka B. In vitro production of β-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels. Neurosci Lett 1995; 183: 120-3
50. Wisniewski HM, Frackowiak, J. Zoltowska A, Kim KS. Vascular β-amyloid in Alzheimer's disease angiopathy is produced by proliferating and degenerating smooth muscle cells. Amyloid: Int J Exp Clin Invest 1994; 1: 8-16
51. Wisniewski HM, Ghetti B, Terry RD. Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys. J Neuropath Exp Neurol 1973; 32: 566-84
52. Wisniewski HM, Johnson AB, Raine CS, Kay WK, Terry RD. Senile plaques and cerebral amyloidosis in aged dogs. Lab Invest 1970; 23: 287-96
53. Wisniewski HM, Kozlowski PB. Evidence for blood-brain barrier changes in senile dementia of the Alzheimer type (SDAT). Ann NY Acad Sci 1982; 396: 119-29
54. Wisniewski HM, Vorbrodt AW, Wegiel J, Morys J, Lossinsky AS. Ultrastructure of the cells forming amyloid fibers in Alzheimer's disease and scrapie. Am J Med Genet Supp 1990; 7: 287-97
55. Wisniewski HM, Wegiel J. Migration of perivascular cells into the neuropil and their involvement in β-amyloid plaque formation. Acta Neuropathol 1993; 85: 586-95
56. Wisniewski HM, Wegiel J. β-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol 1994; 87: 233-41
57. Wisniewski HM, Wegiel J. Commentary - Do neurofibrillary tangles initiate plaque formation, or is it β-amyloidosis that leads to NFT pathology? Neurobiol Aging 1995; 16: 341-3
58. Wisniewski HM, Wegiel J, Popovitch ER. Age-associated development of diffuse and thioflavine-S-positive plaques in Down syndrome. Dev Brain Dysfunct 1994; 7: 330-9
59. Wisniewski HM, Wegiel J, Wang KC, Kujawa M, Lach B. Ultrastructural studies of the cells forming amyloid fibers in classical plaques. Can J Neurol Sci 1989; 16: 535-42
60. Wisniewski HM, Wegiel J, Wang KC, Lach B. Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease. Acta Neuropathol 1992; 84: 117-27
61. Wisniewski T, Ghiso J, Frangione B. Alzheimer's disease and soluble Aβ. Neurobiol Aging 1994; 15: 143-52